Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 58

1.

Diagnostic, évaluation et prise en charge des troubles hypertensifs de la grossesse : Résumé directif.

Magee LA, Pels A, Helewa M, Rey E, von Dadelszen P.

J Obstet Gynaecol Can. 2016 Dec;38(12S):S426-S452. doi: 10.1016/j.jogc.2016.09.052. Epub 2017 Jan 4. No abstract available.

PMID:
28063555
2.

Women's views and postpartum follow-up in the CHIPS Trial (Control of Hypertension in Pregnancy Study).

Vidler M, Magee LA, von Dadelszen P, Rey E, Ross S, Asztalos E, Murphy KE, Menzies J, Sanchez J, Singer J, Gafni A, Gruslin A, Helewa M, Hutton E, Lee SK, Lee T, Logan AG, Ganzevoort W, Welch R, Thornton JG, Moutquin JM; CHIPS Study Group.

Eur J Obstet Gynecol Reprod Biol. 2016 Nov;206:105-113. doi: 10.1016/j.ejogrb.2016.07.509. Epub 2016 Sep 10.

3.

The CHIPS Randomized Controlled Trial (Control of Hypertension in Pregnancy Study): Is Severe Hypertension Just an Elevated Blood Pressure?

Magee LA, von Dadelszen P, Singer J, Lee T, Rey E, Ross S, Asztalos E, Murphy KE, Menzies J, Sanchez J, Gafni A, Helewa M, Hutton E, Koren G, Lee SK, Logan AG, Ganzevoort W, Welch R, Thornton JG, Moutquin JM; CHIPS Study Group*.

Hypertension. 2016 Nov;68(5):1153-1159. Epub 2016 Sep 12.

4.

The Cost Implications of Less Tight Versus Tight Control of Hypertension in Pregnancy (CHIPS Trial).

Ahmed RJ, Gafni A, Hutton EK, Hu ZJ, Pullenayegum E, von Dadelszen P, Rey E, Ross S, Asztalos E, Murphy KE, Menzies J, Sanchez JJ, Ganzevoort W, Helewa M, Lee SK, Lee T, Logan AG, Moutquin JM, Singer J, Thornton JG, Welch R, Magee LA.

Hypertension. 2016 Oct;68(4):1049-55. doi: 10.1161/HYPERTENSIONAHA.116.07466. Epub 2016 Aug 22.

5.

Can adverse maternal and perinatal outcomes be predicted when blood pressure becomes elevated? Secondary analyses from the CHIPS (Control of Hypertension In Pregnancy Study) randomized controlled trial.

Magee LA, von Dadelszen P, Singer J, Lee T, Rey E, Ross S, Asztalos E, Murphy KE, Menzies J, Sanchez J, Gafni A, Gruslin A, Helewa M, Hutton E, Lee SK, Logan AG, Ganzevoort W, Welch R, Thornton JG, Moutquin JM.

Acta Obstet Gynecol Scand. 2016 Jul;95(7):763-76. doi: 10.1111/aogs.12877. Epub 2016 Apr 7.

6.

Letter to the Editor: In Response.

Magee LA, Pels A, Helewa M, Rey E, von Dadelszen P, Bujold E, Côté AM, Douglas MJ, Eastabrook G, Firoz T, Gibson P, Gruslin A, Hutcheon J, Koren G, Lange I, Leduc L, Logan AG, MacDonell KL, Moutquin JM, Sebbag I, Audibert F; Canadian Hypertensive Disorders of Pregnancy (HDP) Working Group.

J Obstet Gynaecol Can. 2015 Sep;37(9):775-776. doi: 10.1016/S1701-2163(15)30146-8. No abstract available.

PMID:
26605445
7.

Do labetalol and methyldopa have different effects on pregnancy outcome? Analysis of data from the Control of Hypertension In Pregnancy Study (CHIPS) trial.

Magee LA; CHIPS Study Group, von Dadelszen P, Singer J, Lee T, Rey E, Ross S, Asztalos E, Murphy KE, Menzies J, Sanchez J, Gafni A, Gruslin A, Helewa M, Hutton E, Koren G, Lee SK, Logan AG, Ganzevoort JW, Welch R, Thornton JG, Moutquin JM.

BJOG. 2016 Jun;123(7):1143-51. doi: 10.1111/1471-0528.13569. Epub 2015 Aug 11.

8.

Control of Hypertension In Pregnancy Study randomised controlled trial-are the results dependent on the choice of labetalol or methyldopa?

Magee LA; CHIPS Study Group, von Dadelszen P, Singer J, Lee T, Rey E, Ross S, Asztalos E, Murphy KE, Menzies J, Sanchez J, Gafni A, Gruslin A, Helewa M, Hutton E, Koren G, Lee SK, Logan AG, Ganzevoort JW, Welch R, Thornton JG, Moutquin JM.

BJOG. 2016 Jun;123(7):1135-41. doi: 10.1111/1471-0528.13568. Epub 2015 Aug 11.

9.

The hypertensive disorders of pregnancy (29.3).

Magee LA, Pels A, Helewa M, Rey E, von Dadelszen P; Canadian Hypertensive Disorders of Pregnancy (HDP) Working Group; Canadian Hypertensive Disorders of Pregnancy HDP Working Group.

Best Pract Res Clin Obstet Gynaecol. 2015 Jul;29(5):643-57. doi: 10.1016/j.bpobgyn.2015.04.001. Epub 2015 Apr 25. Review.

PMID:
26141795
10.

Induction of labour: review.

Leduc D, Biringer A, Lee L, Dy J; Clinical Practice Obstetrics Committee, Azzam H, Barrett J, Biringer A, Campbell K, Duperron L, Dy J, Giesbrecht E, Graves L, Helewa M, Lange I, Lee L, Muise S, Parish B.

J Obstet Gynaecol Can. 2015 Apr;37(4):380-3. Review. English, French. No abstract available.

PMID:
26001692
11.

Less-tight versus tight control of hypertension in pregnancy.

Magee LA, von Dadelszen P, Rey E, Ross S, Asztalos E, Murphy KE, Menzies J, Sanchez J, Singer J, Gafni A, Gruslin A, Helewa M, Hutton E, Lee SK, Lee T, Logan AG, Ganzevoort W, Welch R, Thornton JG, Moutquin JM.

N Engl J Med. 2015 Jan 29;372(5):407-17. doi: 10.1056/NEJMoa1404595.

12.

Barriers and facilitators related to use of prenatal care by inner-city women: perceptions of health care providers.

Heaman MI, Sword W, Elliott L, Moffatt M, Helewa ME, Morris H, Gregory P, Tjaden L, Cook C.

BMC Pregnancy Childbirth. 2015 Jan 16;15:2. doi: 10.1186/s12884-015-0431-5.

13.

Perceptions of barriers, facilitators and motivators related to use of prenatal care: A qualitative descriptive study of inner-city women in Winnipeg, Canada.

Heaman MI, Sword W, Elliott L, Moffatt M, Helewa ME, Morris H, Tjaden L, Gregory P, Cook C.

SAGE Open Med. 2015 Dec 15;3:2050312115621314. doi: 10.1177/2050312115621314. eCollection 2015.

14.

Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summary.

Magee LA, Pels A, Helewa M, Rey E, von Dadelszen P; SOGC Hypertension Guideline Committee.

J Obstet Gynaecol Can. 2014 Jul;36(7):575-576. doi: 10.1016/S1701-2163(15)30533-8. No abstract available.

PMID:
25184972
15.

Barriers, motivators and facilitators related to prenatal care utilization among inner-city women in Winnipeg, Canada: a case-control study.

Heaman MI, Moffatt M, Elliott L, Sword W, Helewa ME, Morris H, Gregory P, Tjaden L, Cook C.

BMC Pregnancy Childbirth. 2014 Jul 15;14:227. doi: 10.1186/1471-2393-14-227.

16.

Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summary.

Magee LA, Pels A, Helewa M, Rey E, von Dadelszen P; Canadian Hypertensive Disorders of Pregnancy Working Group.

J Obstet Gynaecol Can. 2014 May;36(5):416-41. English, French.

PMID:
24927294
17.

Quality of prenatal care questionnaire: instrument development and testing.

Heaman MI, Sword WA, Akhtar-Danesh N, Bradford A, Tough S, Janssen PA, Young DC, Kingston DA, Hutton EK, Helewa ME.

BMC Pregnancy Childbirth. 2014 Jun 3;14:188. doi: 10.1186/1471-2393-14-188.

18.

Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy.

Magee LA, Pels A, Helewa M, Rey E, von Dadelszen P; Canadian Hypertensive Disorders of Pregnancy (HDP) Working Group.

Pregnancy Hypertens. 2014 Apr;4(2):105-45. doi: 10.1016/j.preghy.2014.01.003. Epub 2014 Feb 25. Review.

19.

Cardiovascular magnetic resonance in pregnancy: insights from the cardiac hemodynamic imaging and remodeling in pregnancy (CHIRP) study.

Ducas RA, Elliott JE, Melnyk SF, Premecz S, daSilva M, Cleverley K, Wtorek P, Mackenzie GS, Helewa ME, Jassal DS.

J Cardiovasc Magn Reson. 2014 Jan 3;16:1. doi: 10.1186/1532-429X-16-1.

20.

Multiple courses of antenatal corticosteroids for preterm birth study: outcomes in children at 5 years of age (MACS-5).

Asztalos EV, Murphy KE, Willan AR, Matthews SG, Ohlsson A, Saigal S, Armson BA, Kelly EN, Delisle MF, Gafni A, Lee SK, Sananes R, Rovet J, Guselle P, Amankwah K, Saleem M, Sanchez J; MACS-5 Collaborative Group.

JAMA Pediatr. 2013 Dec;167(12):1102-10. doi: 10.1001/jamapediatrics.2013.2764.

PMID:
24126948

Supplemental Content

Loading ...
Support Center